Cargando…
Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
BACKGROUND: The rate of urinary tract infections (UTIs) due to extended-spectrum β-lactamase (ESBL)-producing bacterial strains requiring carbapenem therapy has been increasing in children. This study was conducted to evaluate the effect of non-carbapenem antibiotic therapy on childhood UTIs caused...
Autores principales: | Han, Seung Beom, Lee, Sung Chul, Lee, Soo Young, Jeong, Dae Chul, Kang, Jin Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604622/ https://www.ncbi.nlm.nih.gov/pubmed/26464143 http://dx.doi.org/10.1186/s12879-015-1153-z |
Ejemplares similares
-
Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
por: Vachvanichsanong, P., et al.
Publicado: (2020) -
Analysis of drug resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in children with urinary tract infection
por: Keshi, Lu, et al.
Publicado: (2019) -
Efficacy of cefoxitin for the treatment of urinary tract infection
due to extended-spectrum-beta-lactamase-producing Escherichia
coli and Klebsiella pneumoniae
isolates
por: Senard, Olivia, et al.
Publicado: (2018) -
Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species
por: Koksal, Eda, et al.
Publicado: (2019) -
Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Cho, Sung-Yeon, et al.
Publicado: (2016)